Figure 3From: Capecitabine and irinotecan with bevacizumab 2-weekly for metastatic colorectal cancer: the phase II AVAXIRI studyChanges in quality of life over the first 11 cycles of treatment as measured by the EuroQoL 5-Dimensions (3-level) questionnaire and patients’ VAS assessment of general health. Abbreviation: VAS = visual analogue scale.Back to article page